UPDATE: Kindred Biosciences Reports Results from PIVOTAL Study of CereKin in Dogs, Primary Endpoint Was Not Met
August 20, 2014 at 16:02 PM EDT
Kindred Biosciences, Inc. (KindredBio, NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, ...